Concepedia

Leticia Arrington

LA

5

Publications

148

Citations

5

H-Index

2012

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Leticia Arrington is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in engineering, nanomedicine, and nanoparticles.

ORCID

Top concepts

Publications per year

2012–2022

5

Publications

5

Stabilization of Ostwald Ripening in Low Molecular Weight Amino Lipid Nanoparticles for Systemic Delivery of siRNA Therapeutics

Marian E. Gindy, Brad Feuston, Angela Glass et al. · Molecular Pharmaceutics · 2014 · 61 citations

, , +16

Assessing the Heterogeneity Level in Lipid Nanoparticles for siRNA Delivery: Size-Based Separation, Compositional Heterogeneity, and Impact on Bioperformance

Jingtao Zhang, Yi Pei, Hangchun Zhang et al. · Molecular Pharmaceutics · 2012 · 34 citations

, , +18

The development of an in vitro assay to screen lipid based nanoparticles for siRNA delivery

Ye Zhang, Leticia Arrington, D. I. Boardman et al. · Journal of Controlled Release · 2013 · 28 citations

, , +7

Population Pharmacokinetics of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: An Integrated Analysis

Maria E. Trujillo, Leticia Arrington, Yogesh T. Patel et al. · Clinical Pharmacology & Therapeutics · 2022 · 13 citations

Performance of longitudinal item response theory models in shortened or partial assessments

Leticia Arrington, Sebastian Ueckert, Malidi Ahamadi et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2020 · 12 citations · Full text

Rows per page

1–5 of 5